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Background
•	 	Microscopic polyangiitis (MPA) is a systemic small-vessel 
necrotizing vasculitis with a strong association with anti-
myeloperoxidase anti-neutrophilic cytoplasmic antibodies 
(MPO-ANCA).  MPA has little or no immune deposit and is 
not associated with granulomatous inflammation.1
•	 	In most cases MPA presents with rapidly progressive 
necrotizing glomerulonephritis and occasionally with 
pulmonary hemorrhage.2  Over 70% of patients have 
constitutional symptoms at diagnosis and disease 
manifestations may involve any organ system.3  MPA may 
also present without renal or pulmonary involvement.2,4
•	 	Peripheral neuropathy has frequently been reported as a 
symptom of ANCA-associated vasculitis and is commonly 
present at disease onset.  It may also be an initial 
manifestation of the disease state, but there is limited 
evidence comparing the incidence of neuropathy with the 
other manifestations of systemic vasculitides.1,4,5
•	 	Studies have shown that a majority of those with ANCA-
associated vasculitis report peripheral neuropathy at some 
point in the disease process, but less than 25% report 
it at initial presentation.  Among the ANCA-associated 
vasculitides, MPA appears to have the lowest incidence of 
reported peripheral neuropathy; sensory or motor.1,5 
•	 	A recent case report of MPA presents a patient with lower 
extremity polyneuropathy preceding renal manifestations.6 
•	 	MPA is treated in two phases: Induction phase is 
acute treatment with systemic corticosteroids and 
immunosuppressive agents such as cyclophosphamide 
or rituximab.  Maintenance phase begins 1-2 months 
after resolution of inflammation and typically involves 
azathioprine.7,8 Patients may also be treated with plasma 
exchange during induction phase.2,8
A 58 year old woman without significant past medical history presented with the 
chief complaints of weakness and loss of balance.  She described a weakness 
and heaviness of her bilateral lower extremities and felt off-balance with difficulty 
ambulating.  She also described a clumsiness and inability to correctly use her left 
hand.
This occurred in the context of a one year history of “pins and needles” sensation in 
her bilateral feet.
Physical exam revealed a stocking-glove distribution of decreased pinprick 
sensation, decreased vibration sense in the bilateral toes, ataxic gait, and a positive 
Romberg sign.  The patient underwent extensive imaging revealing the following 
results:
	 •	 	CT Head: no acute abnormality
	 •	 	MRA Head/Neck: 50% stenosis of proximal right ICA, 75% stenosis of left ICA, 
both felt to be artifactual
	 •	 	MRI Brain: scattered foci of non-specific supratentorial white matter signal 
abnormality, but no acute abnormality 
	 •	 	Chest XR: interstitial prominence laterally at both lung bases most likely 
represents chronic interstitial disease 
	 •	 	2D ECHO: aneurysmal interatrial septum without evidence of shunt, EF 60%
	 •	 	CT Chest: interstitial lung disease, mild mediastinal and hilar adenopathy, mild 
honeycombing at bilateral bases
	 •	 	CT Abd/Pelvis: 6cm cystic right pelvis mass, representing likely ovarian cyst
Laboratory studies revealed an elevated erythrocyte sedimentation rate (ESR) 
and C-reactive protein (CRP), positive rheumatoid factor (RF), and elevated serum 
creatinine.  Patient was ultimately discharged home with a diagnosis of peripheral 
neuropathy likely secondary to thiamine deficiency.
Three months after discharge the patient presented with the acute onset of 
substernal chest pain exacerbated by inspiration and associated with shortness of 
breath.
Initial laboratory examination revealed marked acute oligoanuric renal failure, 
proteinuria, anemia, and new diffuse bilateral perihilar infiltrates on chest x-
ray and CT.  Bronchoscopy revealed acute alveolar hemorrhage.  Further 
laboratory studies demonstrated elevated anti-myeloperoxidase anti-neutrophilic 
cytoplasmic antibodies (MPO-ANCA).  The patient then underwent renal biopsy 
which revealed acute and chronic pauci-immune necrotizing, sclerosing, and 
crescentic glomerulonephritis associated with focal necrotizing vasculitis; typical of 
changes seen with MPO-ANCA seropositivity, leading to a diagnosis of microscopic 
polyangiitis.
The patient was initiated on hemodialysis due to her rapidly progressive 
glomerulonephritis.  She was treated with pulse dose methylprednisolone followed 
by stress dose prednisone, as well as therapeutic plasma exchange and oral 
cyclophosphamide. Her maintenance phase included azathioprine and prednisone.  
Her peripheral neuropathy persists despite treatment.  She remains dialysis 
dependent despite two weaning attempts and is currently undergoing transplant 
evaluation. 
Discussion
Our case is a rare presentation of microscopic polyangiitis (MPA) 
with concurrent diffuse alveolar hemorrhage and dialysis dependent 
rapidly progressive glomerulonephritis in the setting of long-standing 
bilateral stocking-glove distribution pure sensory symmetric peripheral 
neuropathy.
Previous literature has demonstrated that a majority of those with 
ANCA-associated vasculitis report peripheral neuropathy at some point 
in the disease process, but few had active vasculitic neuropathy at 
baseline.
Patients with vasculitic nephropathy at baseline have a higher median 
number of organ systems involved when compared with those without 
neuropathy, and also reported higher Birmingham Vasculitis Activity 
Scores, which is a clinical checklist of items organized by organ system 
used to determine disease activity.
The European Vasculitis Study Group trials showed that a pure sensory 
neuropathy, which our patient developed early in her disease course, 
was not reported in any patients with MPA.  However, our patient did 
not undergo electrophysiologic confirmation of her neuropathy.
Studies demonstrate that non-specific symptoms may be present for 
months to years prior to diagnosis of MPA. This case demonstrates 
the difficulty of recognizing MPA when only a single organ system 
is involved and that ANCA-associated vasculitis should be included 
on the differential diagnosis of peripheral neuropathy with unclear 
etiology. It also exemplifies the need for further research on peripheral 
neuropathy in systemic vasculitides, specifically in MPA where these 








11.1 / 33 Hemoglobin / Hematocrit 6.2 / 18.1
1.47 Serum Creatinine 5.89
100 ESR 125
2.2 CRP 10.3
780 Rheumatoid Factor 584
CCP Antibody Negative
Negative ANA Panel with Reflex Negative
Negative Lyme Titer  
6.3% HgbA1c 5.9%
ASO Titer 27 (Ref. <240)
Hepatitis/HIV Screen Negative
ACE Level 29 (Ref. <20)
PR3-ANCA (c-ANCA) 6.2 (Ref. <20)
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Polyclonal 
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Table	1.	Selected	laboratory	values	from	two	hospital	admissions.		
Hemoglobin/Hematocrit	and	serum	creatinine	are	from	initial	
presentations.
Figure	1.	Chest	x-ray	from	
second	admission	showing	new	
diffuse	bilateral	perihilar	opacities.
Figure	2.	CT	of	the	chest	from	
second	admission	demonstrating	
alveolar	groundglass	opacities	
and	air	bronchograms.
Figure	3.	Light	microscopy	
of	renal	biopsy	demonstrating	
crescentic	glomerulonephritis.
Figure	4.	Light	microscopy	
of	kidney	biopsy	again	
demonstrating	compression	of	the	
glomerulus	by	a	cellular	crescent.
